Navigation Links
RxElite Registration Statement Suspended
Date:1/4/2008

MERIDIAN, Idaho, Jan. 4 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC Bulletin Board: RXEI), a developer, manufacturer, and marketer of specialty generic prescription drug products, announced today the suspension of their registration statement covering the resale of 53,747,555 shares. The suspension is permitted by the Securities and Exchange Commission in certain cases. The company requested this suspension to protect investors due to material non-public information relating to an acquisition. The Company will release information regarding the acquisition as soon as practical. The suspension of this registration statement is allowable for up to 90 days.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contacts:

Corporate Information

Ph: (208) 288-5550

Toll Free: (800) 414-1901

Fax: (208) 288-1191

Investor Relations

Charlie Forshee, 215-885-4981

investorrelations@rxelite.com

Segue Ventures LLC


'/>"/>
SOURCE RxElite, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. RxElite Files Registration Statement with Securities and Exchange Commission
2. RxElite Announces 3rd Quarter Financials Conference Call
3. RxElite Registration Statement Declared Effective by Securities and Exchange Commission
4. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
5. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
6. Gentiva(R) Health Services Files Universal Shelf Registration Statement
7. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
8. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
9. Pearson Introduces Smart Technology for Collecting Patient Registration Information
10. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
11. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2018)... ... December 13, 2018 , ... ... Speakers Bureau for presentations at hospital grand rounds, medical schools, medical conferences and ... medical professionals the evidence-based training in Lifestyle Medicine—using lifestyle prescriptions as a therapeutic ...
(Date:12/10/2018)... ... ... In the aftermath of 1960s feminist movement, multiple generations of men have ... Too movement. To redress the balance, author Steve Clarke wrote “The Man Book,” a ... they were always meant to be by highlighting the qualities and behaviors of a ...
(Date:12/10/2018)... ... December 10, 2018 , ... Loma Linda University School of Public ... California and found a link with freight-railyard pollution to asthma-related emergency room visits in ... , This large-scale railyard study is a follow-up to the i nitial study ...
(Date:12/10/2018)... ... ... The most active U.S. markets in the cannabis industry-- California, Massachusetts and the ... leading B2B trade shows and conferences. , The 2019 dates and locations ... Convention Center, New York, NY , 6th Annual CWCBExpo Los Angeles, September 25-28, 2019, ...
(Date:12/8/2018)... ... 07, 2018 , ... Dr. Masi Reynolds is a certified ... with a valued expertise in minimally-invasive orthopedic care. Dr. Reynolds brings a widespread ... the latest and least-invasive treatment options available in orthopedics. To this end, he ...
Breaking Medicine News(10 mins):
(Date:12/13/2018)... REDWOOD CITY, Calif. (PRWEB) , ... December 13, ... ... company transforming infectious disease diagnostics with genomics, announced today the results of an ... The early findings showed that the Karius® Test, a non-invasive blood test that ...
(Date:12/10/2018)... (PRWEB) , ... December 10, 2018 , ... ... are pleased to announce the formation of Parkview Dental Partners (“Parkview Dental”), a ... Dr. Kenneth Liszewski, founder of BayView Dental, a group dental practice comprised of ...
(Date:12/8/2018)... ... December 07, 2018 , ... ... practice management organizations in the nation, and Southwestern Eye Center, an affiliate of ... The affiliation of the two businesses will improve the quality of care for ...
Breaking Medicine Technology: